rs667773

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001368894.2(PAX6):​c.808-12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0583 in 1,613,838 control chromosomes in the GnomAD database, including 3,847 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.062 ( 401 hom., cov: 32)
Exomes 𝑓: 0.058 ( 3446 hom. )

Consequence

PAX6
NM_001368894.2 intron

Scores

2
Splicing: ADA: 0.00001295
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:16

Conservation

PhyloP100: -0.149

Publications

23 publications found
Variant links:
Genes affected
PAX6 (HGNC:8620): (paired box 6) This gene encodes paired box protein Pax-6, one of many human homologs of the Drosophila melanogaster gene prd. In addition to a conserved paired box domain, a hallmark feature of this gene family, the encoded protein also contains a homeobox domain. Both domains are known to bind DNA and function as regulators of gene transcription. Activity of this protein is key in the development of neural tissues, particularly the eye. This gene is regulated by multiple enhancers located up to hundreds of kilobases distant from this locus. Mutations in this gene or in the enhancer regions can cause ocular disorders such as aniridia and Peter's anomaly. Use of alternate promoters and alternative splicing results in multiple transcript variants encoding different isoforms. Interestingly, inclusion of a particular alternate coding exon has been shown to increase the length of the paired box domain and alter its DNA binding specificity. Consequently, isoforms that carry the shorter paired box domain regulate a different set of genes compared to the isoforms carrying the longer paired box domain. [provided by RefSeq, Mar 2019]
PAX6 Gene-Disease associations (from GenCC):
  • aniridia 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • PAX6-related ocular dysgenesis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Peters anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • coloboma, ocular, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • foveal hypoplasia-presenile cataract syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated aniridia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated optic nerve hypoplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant keratitis
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-31793814-G-A is Benign according to our data. Variant chr11-31793814-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 258168.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX6NM_001368894.2 linkc.808-12C>T intron_variant Intron 10 of 13 ENST00000640368.2 NP_001355823.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX6ENST00000640368.2 linkc.808-12C>T intron_variant Intron 10 of 13 5 NM_001368894.2 ENSP00000492024.1

Frequencies

GnomAD3 genomes
AF:
0.0617
AC:
9378
AN:
152074
Hom.:
401
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0418
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.0718
Gnomad EAS
AF:
0.193
Gnomad SAS
AF:
0.0689
Gnomad FIN
AF:
0.0499
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.0492
Gnomad OTH
AF:
0.0718
GnomAD2 exomes
AF:
0.0851
AC:
21382
AN:
251158
AF XY:
0.0795
show subpopulations
Gnomad AFR exome
AF:
0.0386
Gnomad AMR exome
AF:
0.201
Gnomad ASJ exome
AF:
0.0813
Gnomad EAS exome
AF:
0.198
Gnomad FIN exome
AF:
0.0496
Gnomad NFE exome
AF:
0.0501
Gnomad OTH exome
AF:
0.0822
GnomAD4 exome
AF:
0.0579
AC:
84652
AN:
1461646
Hom.:
3446
Cov.:
33
AF XY:
0.0576
AC XY:
41876
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.0436
AC:
1459
AN:
33476
American (AMR)
AF:
0.193
AC:
8625
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0745
AC:
1947
AN:
26132
East Asian (EAS)
AF:
0.148
AC:
5893
AN:
39694
South Asian (SAS)
AF:
0.0697
AC:
6008
AN:
86254
European-Finnish (FIN)
AF:
0.0520
AC:
2776
AN:
53406
Middle Eastern (MID)
AF:
0.124
AC:
718
AN:
5768
European-Non Finnish (NFE)
AF:
0.0476
AC:
52947
AN:
1111816
Other (OTH)
AF:
0.0709
AC:
4279
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
4721
9442
14162
18883
23604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2182
4364
6546
8728
10910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0616
AC:
9373
AN:
152192
Hom.:
401
Cov.:
32
AF XY:
0.0639
AC XY:
4756
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0418
AC:
1736
AN:
41514
American (AMR)
AF:
0.130
AC:
1988
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0718
AC:
249
AN:
3470
East Asian (EAS)
AF:
0.193
AC:
996
AN:
5164
South Asian (SAS)
AF:
0.0681
AC:
328
AN:
4814
European-Finnish (FIN)
AF:
0.0499
AC:
529
AN:
10610
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.0492
AC:
3348
AN:
68010
Other (OTH)
AF:
0.0710
AC:
150
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
431
862
1292
1723
2154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0558
Hom.:
89
Bravo
AF:
0.0704
Asia WGS
AF:
0.139
AC:
481
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:16
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:7
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 09, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Abnormality of refraction Uncertain:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Mutations in PAX6 can predispose to neonatal diabetes along with extra pancreatic manifestation of optic abnormalities. However, no sufficient evidence was found for the role of rs667773 variant in Diabetes Mellitus yet. -

carboxymethyl-dextran-A2-gadolinium-DOTA Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Aniridia 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Foveal hypoplasia 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

11p partial monosomy syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Aniridia 1;C0344559:Irido-corneo-trabecular dysgenesis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant keratitis Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19390808, 18776953, 12868034, 9727514, 27884173) -

Aniridia, Cerebellar Ataxia, And Intellectual Disability Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Anophthalmia-microphthalmia syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.7
DANN
Benign
0.50
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000013
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs667773; hg19: chr11-31815362; COSMIC: COSV53795119; COSMIC: COSV53795119; API